Dynavox Group (DYVOX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Jun, 2026Executive summary
Achieved record quarterly and full-year revenue and profit growth in 2024, with Q4 revenue up 24% year-over-year and strong expansion across all regions, especially North America and among children with autism.
Organic growth was 21% in Q4, with M&A contributing 1%; strategic investments in sales, systems, and product development are driving scalability and margin improvements.
Completed acquisition of Link Assistive in Australia and New Zealand, enhancing market presence and integration.
Consolidated product development organization at Stockholm headquarters to support innovation.
Financial highlights
Q4 2024 revenue reached SEK 585 million, up 24% year-over-year (22% currency-adjusted); full-year revenue was SEK 1,972 million, up 22%.
Q4 EBIT increased 47% to SEK 83 million, with margin rising to 14.2% from 11.9%; full-year EBIT up 48% to SEK 229 million, margin at 11.6%.
Earnings per share rose 19% in Q4 to SEK 0.51 and 40% for the full year to SEK 1.39.
Gross margin improved to 70% in Q4 and 69% for the year.
Cash flow after continuous investments was SEK 39 million in Q4 and SEK 99 million for the year.
Outlook and guidance
Confident in maintaining 20% annual revenue growth target and EBIT margin above 15% over the next 3–4 years, supported by market expansion and operational excellence.
Ongoing investments in people, systems, and innovation to support future scalability.
No dividend proposed for 2024 to prioritize growth investments and maintain flexibility.
Expect normal seasonality in 2025, with Q1 typically weaker and Q4 strongest.
Latest events from Dynavox Group
- Q1 revenue up 15% (FX-adjusted), EBIT up 35%, strong cash flow, and robust European growth.DYVOX
Q1 202626 Apr 2026 - TD Snap Core First enables flexible, personalized AAC communication for users of all ages.DYVOX
Status update8 Apr 2026 - Q4 revenue up 31% in local currency, EBIT and EPS rose, with strong growth and positive outlook.DYVOX
Q4 20255 Feb 2026 - Q2 revenue up 25% and profit more than doubled, with expansion into Australia and New Zealand.DYVOX
Q2 20243 Feb 2026 - Q3 revenue and EBIT rose, margins improved, and Link Assistive acquisition expanded market reach.DYVOX
Q3 202419 Jan 2026 - Revenue up 36% and EBIT up 32%, with strong autism segment growth and Cenomy acquisition.DYVOX
Q1 202523 Dec 2025 - Q2 revenue up 38% year-over-year; margins fell on currency and one-time costs, outlook strong.DYVOX
Q2 202516 Nov 2025 - Revenue grew 35% in local currencies, with strong direct market gains and key acquisitions.DYVOX
Q3 202523 Oct 2025